Reports

Ideas That Generate Results

Indian Generic Drug Market Outlook 2020

Indian Generic Drug Market Outlook 2020

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Sep, 2015| No. of Pages : 90

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 800.00
CD-ROM Mail Delivery
US$ 900.00
Hard Copy Mail Delivery
US$ 900.00
Electronic Access - Multi-User License
US$ 1100.00

List of Figures:

Figure 3-1: Breakdown of India Pharmaceutical Market by Value (%) 2009-2014
Figure 3-2: Domestic Pharmaceutical Market (Billion US$) 2014-2020
Figure 4-1: Healthcare Expenditure (% of GDP) 2009-2014
Figure 4-2: Personal Disposable Income (Billion US$) 2009-2014
Figure 4-3: Population Above 65 Years (Million) 2009-2014
Figure 4-4: Diabetes Population (20-79 Years) Million 2013 & 2030
Figure 4-5: Number of Cancer Cases (‘000) 2014 & 2020
Figure 6-1: Generic Supply Chain
Figure 7-1: Hierarchy of Ministry for Generic Drug Regulation
Figure 8-1: Share of India in Global Generics Market (%) 2014
Figure 8-2: India Generics Drug Market (Billion US$) 2009-2014
Figure 8-3: Revenue Share of Major Generics Segments (%) 2014
Figure 11-1: Sun Pharma - Break up of Revenue by Therapeutic Segment (%), 2014
Figure 11-2: Sun Pharma - Break up of Revenue by Geography (%), 2014
Figure 11-3: Cipla Limited - Break up of Revenue by Geography (%), 2014
Figure 11-4: Biocon - Break up of Revenue by Geography (%), 2014
Figure 11-5: Dr. Reddy's Laboratories - Break up of Revenue by Geography (%), 2014
Figure 11-6: Lupin Limited - Revenues by Trade (Billion US$), 2014
Figure 11-7: Aurobindo Pharma Limited - Break up of Formulations Revenue of by Geography (%), 2014
Figure 11-8: Wockhardt - Break up of Revenue by Geography (%), 2014
Figure 11-9: Zydus Cadila - Break up of Revenue by Geography (%), 2014
Figure 11-10: Glenmark - Break up of Revenue by Geography (%), 2014
Figure 11-11: Jubilant LifeSciences - Break up of Revenue by Geography (%), 2014
Figure 12-1: Generics Drug Market (Billion US$) 2014-2020

List of Tables:

Table 4-1: List of Blockbustor Drugs Losing Patent (2015-2020)
Table 8-1: Similarities and Differences Between Branded & Generics Drugs
Table 8-2: Top Generic Drugs Globally by Prescription (Million) 2014
Table 9-1: Major Consolidations in Indian Generic Industry (2014-2015)
Table 10-1: Comparative analysis of Jan Aushadhi Scheme (2008 & 2013)
Table 10-2: Pricing Details of Medicines under JAS Scheme
Table 10-3: Free Drugs Provided by States
Table 11-1: Market Share of Key Generics Players (%), 2014
Table 11-2: Sun Pharma - Revenues by Business Segment (Billion US$), 2013 & 2014
Table 11-3: Biocon - Revenues by Business Segment (Billion US$), 2013 & 2014
Table 11-4: Dr. Reddy's Laboratories - Revenues by Business Segment (Billion US$), 2013 & 2014
Table 11-5: Lupin Limited - Revenues by Business Segment (Billion US$), 2013 & 2014
Table 11-6: Aurobindo Pharma Limited - Revenues by Business Segment (Billion US$), 2013 & 2014
Table 11-7: Zydus Cadila - Revenues by Business Segment (Billion US$), 2013 & 2014
Table 11-8: Glenmark - Revenues by Business Segment (Billion US$), 2013 & 2014
Table 11-9: Jubilant LifeSciences - Revenues by Business Segment (Billion US$), 2013 & 2014

Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.